![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Chen Yiming Borthakur Gautam
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.3, 2013-03, pp. : 389-397
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel and Emerging Drugs for Acute Myeloid Leukemia
Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia
Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)